The German DAX contract (DE40) is down more than 1.5% today, and the technical setup on the chart is looking increasingly challenging for bulls. The index has already dropped by nearly 1,000 points from its all-time high.
- The DAX contract is approaching a test of the 50-session exponential moving average (EMA50). The RSI has slipped below 47, and the MACD is showing a bearish crossover of its moving averages. This average currently appears to be acting as an important momentum support, and if it is broken, the path toward a test of the 24,000 area would be opened.
- Declines are also being seen across other European stock markets today, including France and the UK. Sentiment around US assets is also weakening. Markets are being weighed down by uncertainty surrounding the US–Europe trade agreement.
- From February 1, tariffs for eight countries designated by Trump—including Germany, France, and the UK—are likely to rise by 10 percentage points, from the currently applied 15%. Europe is likely to respond with retaliatory measures, potentially targeting Big Tech interests on the Old Continent.
Today’s weakness is visible even in shares of defense group Rheinmetall (RHM.DE), which initially benefited indirectly from the escalation of tensions between Washington and Brussels and London.
DE40 (D1 timeframe)

Source: xStation5
Three Markets to Watch in the Week Ahead (03.04.2026)
Daily Summary: A Lull in the Pre-Holiday Calm
Market wrap 📌US indices in focus amid strong NFP data and $100 oil
BREAKING: NFP payrolls skyrocket 🚀 EURUSD back in red 📉
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.